A sample of saliva could soon determine which patients are at increased risk of developing glaucoma well before the disease can be diagnosed.

It’s business as usual for optometrists who have signed up to MyHeath1st, following the platform’s sale to HealthShare Pty Ltd.

An innovative nonsurgical procedure, which delivers bipolar radiofrequency (RF) technology to delicate subdermal layers of the skin, may soon present optometrists with a new

OrCam – the device that reads text and helps people with vision impairment to recognise faces, banknotes and more – has been upgraded with